Tag - Myomo

Myomo, Inc. Obtains CE Mark Approval for MyoPro®

Myomo, Inc. (NYSE MKT:MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has obtained CE Mark approval for commercial sale of its next-generation MyoPro myoelectric arm orthosis across the European Economic Area (EEA). The CE Mark indicates MyoPro complies with the essential requirements of relevant EU legislation and has achieved quality system certification. MyoPro is the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of […]

Myomo Expands Management Team to Accelerate Commercialization of MyoPro® Powered Orthosis

Myomo®, Inc. (NSYE MKT: MYO), a commercial stage medical robotics company, today announced the expansion of its management team with three new full-time positions in medical affairs, sales and marketing. The expansion marks the company’s accelerated commercialization of its MyoPro line of powered orthoses after raising growth capital through its IPO in June 2017. Read more >>

Robotics Maker CEO Paul Gudonis Explains How Myomo, Inc. Turned Regulation A+ Equity Crowdfunding Into a NYSE Listing

In this podcast, Myomo CEO Paul Gudonis provides his insight on his company’s experience with Reg.A+, from the initial stages to their successful and impressive listing on the NYSE. Mr. Gudonis touches on some extremely important points that anyone in the Regulation A+ realm should know and the advice he gives to potential Reg.A+ issuers is invaluable. Read more >>

Chardon company makes MyoPro brace that helps paralyzed arms function again (video)

MyoPro, developed by Cambridge, Massachusetts-based Myomo Inc., allows patients with partially paralyzed or weakened arms and hands to return to work, do everyday tasks and reduce medical care costs, Myomo said in a statement. The technology could help patients who have suffered strokes, spinal cord or nerve injuries, and people with amyotrohic lateral sclerosis (ALS) or multiple sclerosis. Read more >>